Effects of Carvedilol on Health Outcomes in Heart Failure

Completed · Phase 4

Conditions studied: Heart Failure, Congestive

In brief

The purpose of our study was to determine if a strategy of starting a heart medication (Beta-blocker) before patients leave the hospital and then being seen by a nurse manager would reduce subsequent hospitalizations compared to usual care. Hypothesis: A nurse-directed heart failure management program with inpatient initiation of beta blockers will improve health outcomes in a vulnerable, predominantly Hispanic and African American population.

Key facts

Study ID

NCT00381030

Run by

Denver Health and Hospital Authority

People needed

100

Starts

2002-10-01

Expected to finish

2005-03-01

Last updated by the study team

2006-09-27

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• primary hospitalization with heart failure and LVEF < 40%
• patient informed consent has been obtained
• absence of pulmonary congestion
• age > 18 years

You may not qualify if…

• End-stage renal or hepatic disease
• Acute myocardial infarction as primary diagnosis during index hospitalization
• Life-expectancy < 6-months
• Contraindication to beta blocker use
• Current beta-blocker therapy
• Planned bypass or valve surgery during index hospitalization

Where it is running

• Denver Health Medical Center — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.